Literature DB >> 26255481

[Reconstructing coracoclavicular ligament in treating Rockwood - III Acromioclavicular dislocation by palmaris longus muscle with polyester suture].

Jian-lin Huang, Huan-peng Mo.   

Abstract

OBJECTIVE: To explore therapeutic effects of reconstructing coracoclavicular ligament for the treatment of Rockwood-III Acromioclavicular dislocation by palmaris longus muscle with polyester suture.
METHODS: From August 2011 to November 2013,37 cases with Rockwood-III acromioclavicular dislocation were treated with reconstructing coracoclavicular ligament by palmaris longus muscle with polyester suture. Among patients, 24 were males and 13 were females, ranging the age from 19 to 46 years old, with an average of 32 years old. There were 11 cases on the left side and 26 cases on the right side. Twenty-nine cases were fresh dislocation and 8 cases were old dislocation. Blood loss, operative time were observed, and Karlsson evaltae standard were applied for assessing postoperative recovery of shoulder joint function.
RESULTS: All patients were followed up from 2.5 to 5 months with an average of 3.5 months. Operative time ranged from 52 to 98 (meaned 72) min, blood loss ranged from 50 to 180 (meaned 75) ml. All operative incision were healed at the satge I . According to Karlsson standard, 32 cases obtained excellent results and 5 cases were moderate.
CONCLUSION: For Rockwood-III acromioclavicular dislocation,reconstructing coracoclavicular ligament by palmaris longus muscle with polyester suture has advantages of simple operation, and rapid recovery of shoulder joint function.

Entities:  

Mesh:

Year:  2015        PMID: 26255481

Source DB:  PubMed          Journal:  Zhongguo Gu Shang        ISSN: 1003-0034


  1 in total

1.  Rockwood Grade-III Acromioclavicular Joint Separation: A Cost-Effectiveness Analysis of Treatment Options.

Authors:  Sreten Franovic; Alex Pietroski; Noah Kuhlmann; Talal Bazzi; Yang Zhou; Stephanie Muh
Journal:  JB JS Open Access       Date:  2021-05-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.